Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy

Clinical trial NCT03674294 · COMPLETED

Trial details

NCT number: NCT03674294
Sponsor: Sun Yat-sen University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastrointestinal Neoplasms Chemotherapy-induced Nausea and Vomiting

Start date: 2015-08-04
Primary completion: 2020-03-31
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.